X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1060) 1060
Publication (167) 167
Book Review (24) 24
Book Chapter (13) 13
Newspaper Article (13) 13
Conference Proceeding (2) 2
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
cannabidiol (695) 695
animals (596) 596
index medicus (584) 584
humans (455) 455
cannabidiol - pharmacology (422) 422
male (395) 395
pharmacology & pharmacy (356) 356
cannabinoids (323) 323
mice (293) 293
rats (221) 221
neurosciences (208) 208
marijuana (204) 204
cannabis (198) 198
tetrahydrocannabinol (172) 172
cannabinoids - pharmacology (151) 151
dronabinol - pharmacology (143) 143
female (139) 139
cannabidiol - therapeutic use (128) 128
dose-response relationship, drug (126) 126
delta-tetrahydrocannabinol (112) 112
endocannabinoid system (107) 107
pharmacology (107) 107
analysis (104) 104
delta-9-tetrahydrocannabinol (104) 104
anandamide (101) 101
cannabinoid (100) 100
biochemistry & molecular biology (97) 97
disease models, animal (96) 96
psychiatry (96) 96
clinical neurology (93) 93
cannabidiol - administration & dosage (86) 86
expression (86) 86
cannabidiol - metabolism (84) 84
inflammation (84) 84
metabolism (79) 79
receptor, cannabinoid, cb1 - metabolism (78) 78
receptors (77) 77
cannabinoids - metabolism (76) 76
oxidative stress (76) 76
in-vitro (73) 73
cannabinoids - therapeutic use (70) 70
thc (70) 70
adult (69) 69
receptor (69) 69
activation (68) 68
brain (66) 66
article (65) 65
cannabinoid receptors (65) 65
endocannabinoids (65) 65
mice, inbred c57bl (65) 65
epilepsy (64) 64
rats, wistar (63) 63
cells, cultured (62) 62
health aspects (62) 62
inhibition (62) 62
pharmacokinetics (62) 62
time factors (62) 62
apoptosis (60) 60
cannabinoid receptor (60) 60
neurology (60) 60
research (59) 59
in vitro techniques (58) 58
cannabis - chemistry (57) 57
receptors, cannabinoid - metabolism (57) 57
brain - drug effects (56) 56
brain - metabolism (56) 56
multiple-sclerosis (54) 54
cannabidiol - analogs & derivatives (53) 53
pain (53) 53
drug interactions (52) 52
receptor, cannabinoid, cb2 - metabolism (51) 51
cell biology (50) 50
dronabinol - analogs & derivatives (50) 50
double-blind (49) 49
schizophrenia (49) 49
treatment outcome (49) 49
cancer (48) 48
physiological aspects (48) 48
middle aged (47) 47
cbd (46) 46
cell line, tumor (46) 46
dronabinol - metabolism (46) 46
identification (46) 46
in-vivo (46) 46
medical marijuana (46) 46
anxiety (45) 45
care and treatment (45) 45
multiple sclerosis (45) 45
rats, sprague-dawley (45) 45
cannabidiol - chemistry (44) 44
biomedicine (43) 43
rodents (43) 43
toxicology (43) 43
drug combinations (42) 42
drugs (42) 42
endocannabinoids - metabolism (42) 42
kinetics (42) 42
neuroprotection (42) 42
apoptosis - drug effects (41) 41
digestive system diseases (41) 41
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1072) 1072
Japanese (12) 12
German (4) 4
Portuguese (2) 2
French (1) 1
Hungarian (1) 1
Italian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Neuropharmacology, ISSN 0028-3908, 03/2019, Volume 146, pp. 212 - 221
Journal Article
Biochemical Pharmacology, ISSN 0006-2952, 05/2013, Volume 85, Issue 9, pp. 1306 - 1316
Inflammatory bowel disease (IBD) is an incurable disease which affects millions of people in industrialized countries. Anecdotal and scientific evidence... 
Inflammatory bowel disease | Murine colitis | Phytocannabinoids | Dinitrobenzene sulphonic acid | Macrophages | Cannabigerol | CANNABIDIOL | RAT | PATHOGENESIS | IN-VITRO | SATIVA | EXPERIMENTAL COLITIS | HYPERMOTILITY | DELTA-9-TETRAHYDROCANNABINOL | NITRIC-OXIDE | PHARMACOLOGY & PHARMACY | MICE | Reactive Oxygen Species - metabolism | Epithelial Cells - drug effects | Colon - drug effects | Colitis - pathology | Ki-67 Antigen - metabolism | Male | Interferon-gamma - metabolism | Intestinal Mucosa - drug effects | Interleukin-1beta - metabolism | Inflammatory Bowel Diseases - pathology | Anti-Inflammatory Agents - therapeutic use | Interleukin-10 - metabolism | Colitis - drug therapy | Macrophages, Peritoneal - drug effects | Superoxide Dismutase - metabolism | Inflammatory Bowel Diseases - drug therapy | Cell Line | Anti-Inflammatory Agents - pharmacology | Colon - pathology | Epithelial Cells - pathology | Permeability | Mice, Inbred ICR | Cannabinoids - pharmacology | Receptor, Cannabinoid, CB1 - metabolism | Receptor, Cannabinoid, CB2 - metabolism | Cannabinoids - therapeutic use | Animals | Cyclooxygenase 2 - metabolism | Mice | Macrophages, Peritoneal - metabolism | Intestinal Mucosa - pathology | Nitric Oxide Synthase Type II - metabolism | Peroxidase - metabolism | Psychotropic drugs | Superoxide | Nitric oxide | Ulcerative colitis
Journal Article
Neuropharmacology, ISSN 0028-3908, 10/2017, Volume 125, pp. 319 - 332
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 5/2006, Volume 103, Issue 20, pp. 7895 - 7900
Journal Article
Journal Article
Cell Death and Disease, ISSN 2041-4889, 01/2015, Volume 6, Issue 1, pp. e1601 - e1601
Journal Article
Journal Article
Neurobiology of Disease, ISSN 0969-9961, 2016, Volume 94, pp. 179 - 195
Abstract Pharmacological manipulation of the endocannabinoid system represents a promising therapy to alleviate L-3,4-dihydroxyphenylalanine (L-DOPA)-induced... 
Neurology | AIMs | NF-κB | CB1 | COX-2 | pAcH3 | LID | TRPV-1 | Neuroinflammation | ERK 1/2 | Cannabinoid | PPAR gamma | Anandamide | NITRIC-OXIDE SYNTHASE | PROLIFERATOR-ACTIVATED RECEPTORS | GAMMA PPAR-GAMMA | ABNORMAL INVOLUNTARY MOVEMENTS | NEUROSCIENCES | MESSENGER-RNA LEVELS | RAT MODEL | NF-kappa B | LEVODOPA-INDUCED DYSKINESIA | NF-KAPPA-B | CANNABINOID RECEPTOR AGONIST | PARKINSONS-DISEASE | Endocannabinoids - metabolism | Tyrosine 3-Monooxygenase - metabolism | Dyskinesia, Drug-Induced - physiopathology | Anti-Dyskinesia Agents - toxicity | Capsaicin - pharmacology | Male | NF-kappa B - metabolism | Extracellular Signal-Regulated MAP Kinases - metabolism | Oxidopamine | PPAR gamma - metabolism | TRPV Cation Channels - metabolism | Arachidonic Acids - metabolism | Dyskinesia, Drug-Induced - drug therapy | Parkinsonian Disorders - drug therapy | Parkinsonian Disorders - physiopathology | Mice, Inbred C57BL | Cannabidiol - pharmacology | Capsaicin - analogs & derivatives | Levodopa - toxicity | Dyskinesia, Drug-Induced - pathology | Polyunsaturated Alkamides - metabolism | Brain - drug effects | Receptor, Cannabinoid, CB1 - metabolism | Anti-Dyskinesia Agents - pharmacology | Animals | Parkinsonian Disorders - pathology | Cyclooxygenase 2 - metabolism | Brain - pathology | Histones - metabolism | Physiological aspects | Phenols | COX-2 inhibitors | Fatty acids | Movement disorders
Journal Article
British Journal of Pharmacology, ISSN 0007-1188, 04/2016, Volume 173, Issue 7, pp. 1116 - 1127
Increasing evidence suggests that an overactive endocannabinoid system (ECS) may contribute to the development of diabetes by promoting energy intake and... 
CB1 CANNABINOID RECEPTORS | OXIDATIVE STRESS | LIPID-METABOLISM | CONCISE GUIDE | PHARMACOLOGY | PHARMACOLOGY & PHARMACY | BLOCKADE | PROXIMAL TUBULE | INDUCED INSULIN-RESISTANCE | CELL-DEATH | ADIPOSE-TISSUE | Glucose metabolism | Pancreatic beta cells | Glucose | Analysis | Dextrose | Pancreas | Diabetes | Themed Section | Review
Journal Article
Philosophical Transactions: Biological Sciences, ISSN 0962-8436, 12/2012, Volume 367, Issue 1607, pp. 3364 - 3378
Cannabidiol (CBD) is a major phytocannabinoid present in the Cannabis sativa plant. It lacks the psychotomimetic and other psychotropic effects that the main... 
Receptors | Animal models | Cannabis | Serotonin receptors | Rats | Schizophrenia | Antipsychotic agents | Agonists | Dosage | Antianxiety agents | neuroscience | Articles | behaviour | Psychosis | Cannabidiol | Depression | Anxiety | Serotonin | Anandamide | CARDIOVASCULAR-RESPONSES | PREPULSE INHIBITION | ENDOCANNABINOID SYSTEM | ADULT HIPPOCAMPAL NEUROGENESIS | psychosis | cannabidiol | anxiety | serotonin | DORSOLATERAL PERIAQUEDUCTAL GRAY | CANNABINOID RECEPTOR | NEURAL-BASIS | STRIA TERMINALIS | ANXIOLYTIC-LIKE | BIOLOGY | depression | EQUILIBRATIVE NUCLEOSIDE TRANSPORTER | anandamide | Endocannabinoids - metabolism | Humans | Anti-Anxiety Agents - pharmacology | Cannabidiol - pharmacology | Clinical Trials as Topic | Polyunsaturated Alkamides - metabolism | Neurogenesis | Synaptic Transmission | Dose-Response Relationship, Drug | Psychotic Disorders - metabolism | Depression - drug therapy | Receptor, Cannabinoid, CB1 - metabolism | TRPV Cation Channels - metabolism | Arachidonic Acids - metabolism | Animals | Antidepressive Agents - pharmacology | Anxiety Disorders - metabolism | Psychotic Disorders - drug therapy | Anxiety Disorders - drug therapy | Phytotherapy | Receptor, Serotonin, 5-HT1A - metabolism | Depressive Disorders | Neurotransmitters | Literature Review | Anxiety Disorders | Neuroanatomy | Drug Therapy | Hallucinogenic Drugs | Psychotic Disorders | Psychiatric Disorders | Animal Models | 133 | Review
Journal Article
Environmental Toxicology and Pharmacology, ISSN 1382-6689, 2013, Volume 36, Issue 2, pp. 347 - 357
Journal Article